Pharmacological Effects Of Oral L-citrulline And Tetrahydrobiopterin In Patients With Peripheral Artery Disease
Funder
National Health and Medical Research Council
Funding Amount
$322,283.00
Summary
Citrulline, named after citrullus vulgaris, the watermelon, is a precursor of arginine. Arginine is converted to protective nitric oxide (NO), which is decreased in cardiovascular diseases (CVD). Although arginine supplementation can increase NO availability and improve vascular function it is hampered by a low availability. In contrast, Citrulline is highly available and converted to Arginine. Therefore, this project will explore the therapeutic effects of Citrulline in patients with CVD.